Document is current
Any future updates will be listed below
-
Authors
Ahmidouch, Manal https://orcid.org/0000-0003-0428-1105
Deshpande, Priya
Salib, Christian
Brunner, Patrick
Heller, Patricia
Abdel Azim, Dalia
Ball, Somedeb https://orcid.org/0000-0002-1754-1204
Tremblay, Douglas https://orcid.org/0000-0002-4719-7192
- License Information
-
More Information
Article History
Received: 26 January 2026
Revised: 23 March 2026
Accepted: 14 April 2026
First Online: 27 April 2026
Competing interests
: DT receives contracted research funding paid to his institution from Sobi, Sumitomo, Geron, and Cogent Biosciences and consulting fees from Sobi, Refined Oncology, AbbVie, Pharmaessentia, Geron, GSK and Cogent Biosciences. Somedeb Ball received contracted research funding paid to his institution from Crossbow Therapeutics. Patrick Brunner receives personal fees from Almirall, Sanofi, Janssen, LEO Pharma, AbbVie, Pfizer, Boehringer Ingelheim, GSK, Regeneron, Eli Lilly, Celgene, Novartis, UCB, Merck, RAPT Therapeutics, Galderma, Immunocore, TD Securities, Apogee and Bristol Myers Squibb. PMB receives research support from Pfizer (grant paid to his institution) and is an investigator for Pfizer and Abbvie.
